• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

AVXAF:US

0.0100 USD 0.00000.00%

As of 20:10:00 ET on 06/27/2014.

Snapshot for Avexa Ltd (AVXAF)

Open: - Day's Range: - Volume: 45,000
Previous Close: 0.0100 52wk Range: 0.0100 - 0.0100 1-Yr Rtn: -

Stock Chart for AVXAF

No chart data available.
  • AVXAF:US 0.0100
  • 1D
  • 1M
  • 1Y
0.0100
Interactive AVXAF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AVXAF

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2014) -
Est. PEG Ratio -
Market Cap (M USD) 9.26
Shares Outstanding (M) 925.65
30 Day Average Volume 1,500
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AVXAF

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for AVXAF

Avexa Limited is a pharmaceutical company focused on the research and development of anti-infective drugs for such diseases as HIV, Hepatitis B, and vancomycin resistant bacterial infections.

Jonathan A V CoatesChief Scientific Ofcr/Interim CEOLee MitchellSecretary
M KlapakisController
More Company Profile & Key Executives for AVXAF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil